Company

Rafarma Pharmaceuticals, Inc. (WY)

Headquarters: Sandy, UT, United States

OTC: RAFA +9.52%

Market Cap

$6.1 Million

USD as of July 1, 2024

Market Cap History

Rafarma Pharmaceuticals, Inc. (WY) market capitalization over time

Evolution of Rafarma Pharmaceuticals, Inc. (WY) market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Rafarma Pharmaceuticals, Inc. (WY)

Detailed Description

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-àŸ structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Rafarma Pharmaceuticals, Inc. (WY) has the following listings and related stock indices.


Stock: OTC: RAFA wb_incandescent

Details

Headquarters:

49 West 9000 South

Suite 1

Sandy, UT 84070

United States

Phone: 801-210-7135